Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial

D. H. Johnson, D. Paul, K. R. Hande

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences